DavidLWylesMD
Infectious Disease • Denver, COProfessor of Medicine, University of Colorado School of Medicine. Chief, Division of Infectious Diseases, Denver Health Medical Center
Dr. Wyles is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
777 Bannock St
Denver, CO 80204Phone+1 303-602-5148
Education & Training
University of ColoradoFellowship, Infectious Disease, 2001 - 2004- University of ColoradoResidency, Internal Medicine, 1998 - 2001
Northwestern University The Feinberg School of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 2005 - Present
CO State Medical License 2000 - 2025- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C Start of enrollment: 2014 Jan 01
- Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection Start of enrollment: 2019 Nov 15
Publications & Presentations
PubMed
- 44 citationsIncident Hepatitis C Virus Infection among US HIV-Infected Men Enrolled in Clinical TrialsLynn E. Taylor, Marisa Holubar, Kunling Wu, Ronald J. Bosch, David L. Wyles
Clinical Infectious Diseases. 2011-03-15 - 37 citationsFunctional conservation despite structural divergence in ligand-responsive RNA switches.Mark A. Boerneke, Sergey M. Dibrov, Jing Gu, David L. Wyles, Thomas Hermann
Proceedings of the National Academy of Sciences of the United States of America. 2015-02-18 - 96 citationsEfficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phas...Andre C. Kalil, Aneesh K. Mehta, Thomas F Patterson, Nathaniel B. Erdmann, Carlos A. Gomez
The Lancet. Respiratory Medicine. 2021-10-18
Press Mentions
The CDC Says Fully Vaccinated People Don’t Need Masks Anymore. Here’s What That Means in ColoradoMay 14th, 2021- From Starvation to Overdose, Coronavirus’ Hidden Toll Emerges in Colorado’s Death DataFebruary 17th, 2021
New DAA for Hepatitis C Effective in Large Majority of Patients with Resistance-Associated SubstitutionsAugust 28th, 2018- Join now to see all
Grant Support
- Analysis Of HIV/HCV Sexual Transmission Pairs Using Ultra-Deep SequencingNational Institute Of Allergy And Infectious Diseases2012
- An In Vitro System To Study Antiviral Strategies Against Hepatitis C VirusNational Institute Of Allergy And Infectious Diseases2007–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
